MedImmune And National Institutes Of Health Begin Clinical Testing Of A Live, Attenuated Intranasal Vaccine Against An H5N1 Avian Influenza Virus
submited by kickingbird at Jun, 16, 2006 16:18 PM from Medical News Today
MedImmune, Inc.(Nasdaq: MEDI) announced today that the National Institutes of Health (NIH)has begun enrolling participants in a Phase 1 study of an intranasal H5N1influenza vaccine candidate based on the company´s live, attenuated vaccinetechnology. [click link for full article]
See Also:
Latest news in those days:
- GISAID: H5N1 Bird Flu continues to take its toll in the United States 5 days ago
- UK: Bird flu (avian influenza) - latest situation in England 6 days ago
- US: Fourth Maricopa County poultry facility tests positive for Avian Influenza in Arizona 10 days ago
- GISAID: H5N1 Bird Flu continues to take its toll in the United States 12 days ago
- Bangladesh: Two cases of human infection with avian influenza A(H5N1) reported 14 days ago
[Go Top] [Close Window]
